Categories : Endocrine & Metabolic
Product Packaging : 10 / 30 tablets
Product Composition : 5 mg
Send MessageLinagliptin 5 mg Tablets are advanced oral antidiabetic medications belonging to the DPP-4 (dipeptidyl peptidase-4) inhibitor class, designed to improve glycemic control in adults with type 2 diabetes mellitus. Linagliptin works by enhancing incretin hormone levels, which increase insulin secretion in a glucose-dependent manner while simultaneously reducing glucagon release, thereby lowering blood glucose levels without causing significant hypoglycemia.
Unlike many other antidiabetic agents, Linagliptin has a unique non-renal elimination pathway, making it particularly suitable for patients with renal impairment where dose adjustment is often not required. This makes it a preferred modern therapy in global diabetes management protocols.
Genliva Wellness LLP, Himatnagar, India, is a trusted linagliptin 5 mg tablet manufacturer India, offering high-quality DPP-4 inhibitor formulations for domestic markets as well as international pharmaceutical distribution and contract manufacturing partnerships.
Linagliptin Tablets are DPP-4 inhibitor antidiabetic medications used to improve blood glucose control in patients with type 2 diabetes mellitus. They work by increasing incretin hormone activity, which helps regulate insulin and glucose levels naturally.
These tablets are commonly prescribed for the management of type 2 diabetes mellitus along with diet and exercise. They help improve glycemic control and support balanced blood sugar management.
Linagliptin Tablets provide effective glucose regulation with low risk of hypoglycemia and convenient dosing. They are widely used for improving diabetes management and patient compliance.
